{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T11:49:25Z","timestamp":1692704965440},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2021,4,19]],"date-time":"2021-04-19T00:00:00Z","timestamp":1618790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,4,19]],"date-time":"2021-04-19T00:00:00Z","timestamp":1618790400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hautarzt"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1007\/s00105-021-04805-5","type":"journal-article","created":{"date-parts":[[2021,4,19]],"date-time":"2021-04-19T09:03:16Z","timestamp":1618822996000},"page":"443-450","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Diagnostik und Therapie von sexuell \u00fcbertragbaren Infektionen"],"prefix":"10.1007","volume":"72","author":[{"given":"Anja","family":"Potthoff","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Skaletz-Rorowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N. H.","family":"Brockmeyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,4,19]]},"reference":[{"key":"4805_CR1","unstructured":"Sexuell \u00fcbertragbare Infektionen (STI) \u2013 Beratung, Diagnostik und Therapie. https:\/\/www.awmf.org\/uploads\/tx_szleitlinien\/059-006l_S2k_Sexuell-uebertragbare-Infektionen-Beratung-Diagnostik-Therapie-STI_2019-09.pdf. Zugegriffen: 12. Jan. 2021"},{"key":"4805_CR2","unstructured":"https:\/\/dstig.de\/images\/DSTIG-Flyer\/Leitfaden\/sti-leitfaden%20deutsch%203.0%20-%204web. Zugegriffen: 13. Jan. 2021"},{"key":"4805_CR3","first-page":"111","volume":"4","author":"I Ehrhardt","year":"2012","unstructured":"Ehrhardt\u00a0I (2012) Epidemiologische Aspekte bei Neisseria gonorrhoeae- und Chlamydia trachomatis-Infektionen, unter besonderer Ber\u00fccksichtigung der Meldedaten aus Sachsen. Mikrobiologe 4:111\u2013119","journal-title":"Mikrobiologe"},{"issue":"1","key":"4805_CR4","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s12879-020-4831-4","volume":"20","author":"K Jansen","year":"2020","unstructured":"Jansen\u00a0K, Steffen\u00a0G, Potthoff\u00a0A et\u00a0al (2020) STI in times of PrEP: high prevalence of chlamydia, gonorrhea, and mycoplasma at different anatomic sites in men who have sex with men in Germany. BMC Infect Dis 20(1):110","journal-title":"BMC Infect Dis"},{"issue":"1","key":"4805_CR5","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1111\/jdv.16913","volume":"35","author":"A Skaletz-Rorowski","year":"2020","unstructured":"Skaletz-Rorowski A, Potthoff A, Nambiar S, Wach J, Kayser A, Kasper A, Brockmeyer NH (2020) Sexual behaviour, STI knowledge and Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) prevalence in an asymptomatic cohort in Ruhrarea, Germany: PreYoungGo study. J\u00a0Eur Acad Dermatol Venerol 35(1):241\u2013246","journal-title":"J\u00a0Eur Acad Dermatol Venerol"},{"key":"4805_CR6","unstructured":"https:\/\/www.awmf.org\/uploads\/tx_szleitlinien\/059-005l_S2k_Chlamydia-trachomatis_Infektionen_2016-12.pdf. Zugegriffen: 1. Dez. 2020"},{"issue":"4","key":"4805_CR7","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1136\/sti.2004.012799","volume":"81","author":"LM Niccolai","year":"2005","unstructured":"Niccolai\u00a0LM, Rowhani-Rahbar\u00a0A, Jenkins\u00a0H et al (2005) Condom effectiveness for prevention of Chlamydia trachomatis infection. Sex Transm Infect 81(4):323\u2013325","journal-title":"Sex Transm Infect"},{"issue":"3","key":"4805_CR8","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1093\/aje\/kwh044","volume":"159","author":"L Warner","year":"2004","unstructured":"Warner\u00a0L, Newman\u00a0DR, Austin\u00a0HD et\u00a0al (2004) Condom effectiveness for reducing transmission of gonorrhea and chlamydia: the importance of assessing partner infection status. Am J Epidemiol 159(3):242\u2013251","journal-title":"Am J Epidemiol"},{"key":"4805_CR9","unstructured":"https:\/\/www.awmf.org\/uploads\/tx_szleitlinien\/059-004l_S2k_Gonorrhoe-Diagnostik-Therapie_2019-03.pdf. Zugegriffen: 1. Dez. 2020"},{"issue":"4","key":"4805_CR10","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1136\/sextrans-2017-053384","volume":"94","author":"L Baumann","year":"2018","unstructured":"Baumann\u00a0L, Cina\u00a0M, Egli-Gany\u00a0D et al (2018) Prevalence of mycoplasma genitalium in different population groups: systematic review and meta-analysis. Sex Transm Infect 94(4):255\u2013262","journal-title":"Sex Transm Infect"},{"issue":"6","key":"4805_CR11","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1111\/jdv.13539","volume":"30","author":"W Fuchs","year":"2016","unstructured":"Fuchs\u00a0W, Wieland\u00a0U, Skaletz-Rorowski\u00a0A, Brockmeyer\u00a0NH, Swoboda\u00a0J, Kreuter\u00a0A, Michalik\u00a0C, Potthoff\u00a0A (2016) The male ScreenING Study: prevalence of HPV-related genital and anal lesions in an urban cohort of HIV-positive men in Germany. J\u00a0Eur Acad Dermatol Venereol 30(6):995\u20131001","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"4","key":"4805_CR12","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1093\/cid\/ciy477","volume":"68","author":"T Read","year":"2019","unstructured":"Read\u00a0T, Fairley\u00a0C, Murray\u00a0G (2019) Outcomes of resistance-guided sequential treatment of mycoplasma genitalium infections: a prospective evaluation. Clin Infect Dis 68(4):554\u2013560","journal-title":"Clin Infect Dis"},{"issue":"4","key":"4805_CR13","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1136\/sextrans-2019-054124","volume":"96","author":"M Fern\u00e1ndez-Huerta","year":"2020","unstructured":"Fern\u00e1ndez-Huerta\u00a0M, Barber\u00e1\u00a0MJ, Esperalba\u00a0J et al (2020) Prevalence of Mycoplasma genitalium and macrolide resistance among asymptomatic people visiting a\u00a0point of care service for rapid STI screening: a\u00a0cross-sectional study. Sex Transm Infect 96(4):300\u2013305","journal-title":"Sex Transm Infect"},{"key":"4805_CR14","unstructured":"Syphilis in Deutschland 2019 \u2013 Neuer H\u00f6chststand von Infektionen. https:\/\/www.rki.de\/DE\/Content\/Infekt\/EpidBull\/Archiv\/2020\/Ausgaben\/49_20.pdf?__blob=publicationFile. Zugegriffen: 12. Jan. 2021"},{"key":"4805_CR15","unstructured":"https:\/\/www.awmf.org\/uploads\/tx_szleitlinien\/059-002l_S2k_Diagnostik_Therapie_Syphilis_2020_06_1_01.pdf. Zugegriffen: 1. Dez. 2020"},{"issue":"8","key":"4805_CR16","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1097\/OLQ.0b013e3182536574","volume":"39","author":"K Holman","year":"2012","unstructured":"Holman\u00a0K, Wolff\u00a0M, Se\u00f1a\u00a0A et\u00a0al (2012) Rapid plasma reagin titer variation in the 2\u00a0weeks after syphilis therapy. Sex Transm Dis 39(8):645\u2013647","journal-title":"Sex Transm Dis"},{"issue":"7","key":"4805_CR17","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1097\/OLQ.0b013e3181a396eb","volume":"36","author":"CA Koss","year":"2009","unstructured":"Koss\u00a0CA, Dunne\u00a0EF, Warner\u00a0L (2009) A systematic review of epidemiologic studies assessing condom use and risk of syphilis. Sex Transm Dis 36(7):401\u2013405","journal-title":"Sex Transm Dis"},{"key":"4805_CR18","unstructured":"https:\/\/www.awmf.org\/uploads\/tx_szleitlinien\/082-008k_S2k_HPV_assoziierte_anogenitale_L%C3%A4sionen_2017-10.pdf. Zugegriffen: 1. Dez. 2020"},{"issue":"14","key":"4805_CR19","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1177\/0956462417727194","volume":"28","author":"R Patel","year":"2017","unstructured":"Patel\u00a0R, Kennedy\u00a0OJ, Clarke\u00a0E et\u00a0al (2017) 2017 European guidelines fort he managemnet of geital herpes. Int J STD Aids 28(14):1366\u20131379","journal-title":"Int J STD Aids"},{"issue":"4","key":"4805_CR20","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1071\/SH17190","volume":"15","author":"T Brosh-Nissimov","year":"2018","unstructured":"Brosh-Nissimov T, Kedem R, Ophir N, Shental O, Keller N, Amit S (2018) Management of sexually transmissible infections in the era of multiplexed molecular diagnostics: a\u00a0primary care survey. Sex Health 15(4):298\u2013303","journal-title":"Sex Health"}],"container-title":["Der Hautarzt"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-021-04805-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00105-021-04805-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-021-04805-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,4]],"date-time":"2021-05-04T19:35:39Z","timestamp":1620156939000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00105-021-04805-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,19]]},"references-count":20,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["4805"],"URL":"https:\/\/doi.org\/10.1007\/s00105-021-04805-5","relation":{},"ISSN":["0017-8470","1432-1173"],"issn-type":[{"value":"0017-8470","type":"print"},{"value":"1432-1173","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,19]]},"assertion":[{"value":"10 March 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"Gem\u00e4\u00df den Richtlinien des Springer Medizin Verlags werden Autoren und Wissenschaftliche Leitung im Rahmen der Manuskripterstellung und Manuskriptfreigabe aufgefordert, eine vollst\u00e4ndige Erkl\u00e4rung zu ihren finanziellen und nichtfinanziellen Interessen abzugeben.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"<b>A.\u00a0Potthoff<\/b>: A.\u00a0Finanzielle Interessen: Forschungsf\u00f6rderung des WIR (nicht zur pers\u00f6nlichen Verf\u00fcgung): Bundesministerium f\u00fcr Gesundheit, Ministerium f\u00fcr Arbeit, Gesundheit und Soziales des Landes NRW, Stadt Bochum, Deutsche AIDS Stiftung, ViiV Healthcare GmbH, AbbVie Deutschland GmbH & Co. KG, Cepheid GmbH, Bistum Essen. \u2013\u00a0Teilnehmergeb\u00fchr: AbbVie.\u00a0\u2013 Advisory board: ViiV Healthcare, Gilead Sciences. \u2013\u00a0B.\u00a0Nichtfinanzielle Interessen: Ober\u00e4rztin, Interdisziplin\u00e4re Immunologische Ambulanz, Zentrum f\u00fcr Sexuelle Gesundheit und Medizin, Klinik f\u00fcr Dermatologie, Venerologie und Allergologie, Ruhr Universit\u00e4t Bochum, WIR\u00a0\u2013 Walk In Ruhr, Zentrum f\u00fcr Sexuelle Gesundheit und Medizin, Bochum | Mitgliedschaften: Deutsche Gesellschaft f\u00fcr Infektiologie, DAIG, Landeskommission AIDS NRW, Deutsche STI-Gesellschaft (Vorstand). <b>A.\u00a0Skaletz-Rorowski<\/b>: A.\u00a0Finanzielle Interessen: kein finanzieller Interessenkonflikt. \u2013\u00a0B.\u00a0Nichtfinanzielle Interessen: Gesch\u00e4ftsf\u00fchrerin und wissenschaftliche Koordinatorin, WIR\u00a0\u2013 Walk In Ruhr, Kompetenznetz HIV\/AIDS, Zentrum f\u00fcr Sexuelle Gesundheit und Medizin, Klinik f\u00fcr Dermatologie, Venerologie und Allergologie der Ruhr-Universit\u00e4t Bochum | Mitgliedschaft: Steering Committee des Kompetenznetzes HIV\/AIDS. <b>N.H.\u00a0Brockmeyer<\/b>: A.\u00a0Finanzielle Interessen: kein finanzieller Interessenkonflikt. \u2013\u00a0B.\u00a0Nichtfinanzielle Interessen: Abteilungsleiter WIR\u00a0\u2013 Walk In Ruhr Zentrum f\u00fcr Sexuelle Gesundheit und Medizin, Klinik f\u00fcr Dermatologie, Allergologie und Venerologie der Ruhr Universit\u00e4t Bochum | Mitgliedschaft: Deutsche STI-Gesellschaft (DSTIG, Pr\u00e4sident).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Autoren"}},{"value":"Die vollst\u00e4ndige Erkl\u00e4rung zum Interessenkonflikt der Wissenschaftlichen Leitung finden Sie am Kurs der zertifizierten Fortbildung auf ExternalRef removed.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Wissenschaftliche Leitung"}},{"value":"erkl\u00e4rt, dass f\u00fcr die Publikation dieser CME-Fortbildung keine Sponsorengelder an den Verlag flie\u00dfen.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}}]}}